Mangoceuticals, Inc. Adjustments to Additional Paid in Capital, Other
Mangoceuticals, Inc. (MGRX) reported Adjustments to Additional Paid in Capital, Other of $12.42 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2026-08-13
- Mangoceuticals, Inc. adjustments to additional paid in capital, other for the quarter ending 2026-06-30 was $12.42K, a 75.64% decline year-over-year.
- Mangoceuticals, Inc. adjustments to additional paid in capital, other for the quarter ending 2026-03-31 was $1.09M, a 2038.36% increase year-over-year.
- Mangoceuticals, Inc. adjustments to additional paid in capital, other for the quarter ending 2025-09-30 was $1.10M, a 911.23% increase year-over-year.
- Mangoceuticals, Inc. adjustments to additional paid in capital, other for the quarter ending 2025-06-30 was $50.98K, a 0.00% decline year-over-year.
- Mangoceuticals, Inc. adjustments to additional paid in capital, other for fiscal 2025 was $1.17M, a 369.79% increase from fiscal 2024.
- Mangoceuticals, Inc. adjustments to additional paid in capital, other for fiscal 2024 was $248.68K, a 60.18% decline from fiscal 2023.
- Mangoceuticals, Inc. adjustments to additional paid in capital, other for fiscal 2023 was $624.46K, a 166.76% increase from fiscal 2022.
- Mangoceuticals, Inc. adjustments to additional paid in capital, other for fiscal 2022 was $234.09K.
| Period end | Adjustments to Additional Paid in Capital, Other | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $12.42K 10-Q · filed 2026-08-13 | $1.10M derived: sum of 2 quarters · filed 2026-08-13 | |||
| 2026-03-31 | $1.09M 10-Q · filed 2026-08-13 | ||||
| 2025-12-31 | $1.17M 10-K · filed 2026-04-01 | ||||
| 2025-09-30 | $1.10M 10-Q · filed 2025-11-14 | $1.15M derived: sum of 2 quarters · filed 2026-08-13 | $1.20M derived: sum of 3 quarters · filed 2026-08-13 | ||
| 2025-06-30 | $50.98K 10-Q · filed 2026-08-13 | $101.96K derived: sum of 2 quarters · filed 2026-08-13 | |||
| 2025-06-02 | $23.00 10-Q · filed 2026-08-13 | ||||
| 2025-03-31 | $50.98K 10-Q · filed 2026-08-13 | ||||
| 2024-12-31 | $248.68K 10-K · filed 2026-04-01 | ||||
| 2024-09-30 | $108.76K 10-Q · filed 2025-11-14 | $159.74K derived: sum of 2 quarters · filed 2025-11-14 | $197.70K derived: sum of 3 quarters · filed 2025-11-14 | ||
| 2024-06-30 | $50.98K 10-Q/A · filed 2025-11-14 | $88.94K derived: sum of 2 quarters · filed 2025-11-14 | |||
| 2024-03-31 | $37.97K 10-Q/A · filed 2025-11-14 | ||||
| 2023-12-31 | $624.46K 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | $66.84K 10-Q · filed 2024-11-14 | $131.11K derived: sum of 2 quarters · filed 2024-11-14 | $195.38K derived: sum of 3 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $64.27K 10-Q · filed 2024-11-14 | $128.54K derived: sum of 2 quarters · filed 2024-11-14 | |||
| 2023-03-31 | $64.27K 10-Q · filed 2024-11-14 | ||||
| 2022-12-31 | $234.09K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |